IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity

Thomas, L. in Cellular and Humoral Aspects of Hypersensitivity States (ed. Lawrence, H. S.) 529–532 (Hoeber, New York, 1959).

Burnet, F. M. The concept of immunologic surveillance. Prog. Exp. Tumor Res. 13, 1–27 (1970).

Stutman, O. Spontaneous tumors in nude mice: effect of the viable yellow gene. Exp. Cell. Biol. 47, 129–135 (1979).

Stutman, O. Tumor development after 3-methylcholanthrene in immunologically deficient athymic-nude mice. Science 183, 534–536 (1970).

Stutman, O. Chemical carcinogenesis in nude mice: comparison between nude mice from homozygous and heterozygous matings and effect of age and carcinogen dose. J. Natl Cancer Inst. 2, 353–358 (1979).

Hunig, T. T-cell function and specificity in athymic mice. Immunol. Today 4, 84–87 (1983).

Maleckar, J. R. & Sherman, L. A. The composition of the T cell receptor repertoire in nude mice. J. Immunol. 138, 3873–3876 (1987).

Dighe, A. S., Richards, E., Old, L. J. & Schreiber, R. D. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFNγ receptors. Immunity 1, 447–456 (1994).

Kaplan, D. H. et al. Demonstration of an IFNγ dependent tumor surveillance system in immunocompetent mice. Proc. Natl Acad. Sci. USA 95, 7556–7561 (1998).

van den Broek, M. F. et al. Decreased tumor surveillance in perforin-deficient mice. J. Exp. Med. 184, 1781–1790 (1996).

Smyth, M. J. et al. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 191, 661–668 (2000).

Smyth, M. J. et al. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J. Exp. Med. 192, 755–760 (2000).

Shinkai, Y. et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68, 855–867 (1992).

Meraz, M. A. et al. Targeted disruption of the STAT1 gene in mice reveals unexpected physiologic specificity in the Jak-STAT signaling pathway. Cell 84, 431–442 (1996).

Durbin, J. E., Hackenmiller, R., Simon, M. C. & Levy, D. E. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral infection. Cell 84, 443–450 (1996).

Old, L. J. & Stockert, E. Immunogenetics of cell surface antigens of mouse leukemia. Annu. Rev. Genet. 17, 127–160 (1977).

Marincola, F. M., Jaffee, E. M., Hicklin, D. J. & Ferrone, S. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv. Immunol. 74, 181–273 (2000).

Alimonti, J. et al. TAP expression provides a general method for improving the recognition of malignant cells in vivo. Nature Biotechnol. 18, 515–520 (2000).

Marusina, K., Iyer, M. & Monaco, J. J. Allelic variation in the mouse Tap-1 and Tap-2 transporter genes. J. Immunol. 158, 5251–5256 (1997).

Huang, S. et al. Immune response in mice that lack the interferon-γ receptor. Science 259, 1742–1745 (1993).

Dighe, A. S. et al. Tissue specific targeting of cytokine unresponsiveness in transgenic mice. Immunity 3, 657–666 (1995).